CRISPR Therapeutics (CRSP) News Today $56.09 -0.17 (-0.30%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$56.14 +0.05 (+0.09%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRSP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period CRISPR Therapeutics (CRSP) Sees 47% Price Increase Over Last Quarter3 hours ago | finance.yahoo.comQ2 EPS Forecast for CRISPR Therapeutics Decreased by AnalystAugust 1 at 7:00 AM | marketbeat.comBayforest Capital Ltd Takes Position in CRISPR Therapeutics AG (NASDAQ:CRSP)August 1 at 5:53 AM | marketbeat.comCathie Wood’s ARK buys Prime Medicine, sells CRISPR stockAugust 1 at 2:39 AM | investing.comCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 4.1% - Here's What HappenedJuly 30 at 1:16 PM | marketbeat.comThe 3 Things That Matter for CRISPR Therapeutics NowJuly 29, 2025 | msn.comInspire Advisors LLC Invests $459,000 in CRISPR Therapeutics AG (NASDAQ:CRSP)July 29, 2025 | marketbeat.comJim Cramer Says “CRISPR Can Either Triple or Do Nothing”July 29, 2025 | insidermonkey.comCRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?July 29, 2025 | msn.comCerity Partners LLC Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP)July 29, 2025 | marketbeat.comEnvestnet Asset Management Inc. Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)July 29, 2025 | marketbeat.comCRISPR Therapeutics (CRSP) to Release Quarterly Earnings on MondayJuly 28, 2025 | marketbeat.comARK Investment Management LLC Acquires 1,192,336 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Sells 205,787 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)July 27, 2025 | marketbeat.comCathie Wood’s ARK ETF adjusts portfolio, buys ABSCI, sells CRISPRJuly 25, 2025 | investing.comWhat the Options Market Tells Us About CRISPR TherapeuticsJuly 24, 2025 | benzinga.comCrispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something BigJuly 23, 2025 | seekingalpha.comCRISPR Therapeutics (CRSP) Surges 71% Last Quarter With Inclusion In Russell IndicesJuly 23, 2025 | finance.yahoo.com2 Biotech and 2 Tech Stocks Insiders Are Scooping Up NowJuly 23, 2025 | 247wallst.com$CRSP Is Up 120%—Here’s Why It’s Pure FOMO NowJuly 23, 2025 | msn.comPrivate Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)July 23, 2025 | marketbeat.comBank of America Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $78.00July 22, 2025 | marketbeat.comNearly 89% of Companies are Seeing Insider Selling, But these 3 are Seeing Substantial BuyingJuly 22, 2025 | 247wallst.comCRISPR Therapeutics (NASDAQ:CRSP) Sees Unusually-High Trading Volume - Here's What HappenedJuly 21, 2025 | marketbeat.comQ2 EPS Estimate for CRISPR Therapeutics Reduced by AnalystJuly 21, 2025 | marketbeat.com3 Monster Stocks in the Making to Buy Right NowJuly 20, 2025 | fool.comInsider Buying: CRISPR Therapeutics AG (NASDAQ:CRSP) Director Buys 989,812 Shares of StockJuly 18, 2025 | marketbeat.comCrypto pops on GENIUS Act, Chinese tech stocks, CRISPRJuly 18, 2025 | finance.yahoo.comCRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of SharesJuly 18, 2025 | tipranks.comCRISPR Therapeutics (NASDAQ:CRSP) Hits New 52-Week High Following Insider Buying ActivityJuly 18, 2025 | marketbeat.comCRISPR Therapeutics AG (NASDAQ:CRSP) Director Simeon George Purchases 989,812 SharesJuly 18, 2025 | insidertrades.comWilliam Blair Issues Optimistic Estimate for CRSP EarningsJuly 16, 2025 | marketbeat.comCRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of "Moderate Buy" by AnalystsJuly 16, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 5.7% - Here's What HappenedJuly 15, 2025 | marketbeat.comCrispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)July 14, 2025 | seekingalpha.comCrispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)July 14, 2025 | seekingalpha.comLeavell Investment Management Inc. Invests $340,000 in CRISPR Therapeutics AG (NASDAQ:CRSP)July 13, 2025 | marketbeat.com12,223 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Acquired by B & T Capital Management DBA Alpha Capital ManagementJuly 12, 2025 | marketbeat.comCRISPR Stock Surges in Recent Weeks: What's Going On?July 10, 2025 | benzinga.comCRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech RallyJuly 10, 2025 | msn.comCRISPR Therapeutics (NasdaqGM:CRSP) Advances Cardiovascular Programs With Promising Trial ResultsJuly 10, 2025 | finance.yahoo.comCRISPR Therapeutics Sees Unusually Large Options Volume (NASDAQ:CRSP)July 9, 2025 | marketbeat.comCathie Wood’s ARK buys CRSP stock, sells ROKU and MASSJuly 8, 2025 | investing.comCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 7% - Time to Buy?July 8, 2025 | marketbeat.comCRISPR Therapeutics' (CRSP) Buy Rating Reaffirmed at Needham & Company LLCJuly 8, 2025 | marketbeat.comCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by KBC Group NVJuly 8, 2025 | marketbeat.comCambridge Investment Research Advisors Inc. Grows Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)July 4, 2025 | marketbeat.comCRSP - CRISPR Therapeutics AG Sustainability - MorningstarJuly 3, 2025 | morningstar.comMH.C. Wainwright Reaffirms Buy Rating on CRISPR Therapeutics After CTX310 UpdateJuly 3, 2025 | msn.com2 Beaten-Down Stocks With Massive Upside PotentialJuly 3, 2025 | fool.com Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address CRSP Media Mentions By Week CRSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.460.45▲Average Medical News Sentiment CRSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼1711▲CRSP Articles Average Week Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Allogene Therapeutics News Axsome Therapeutics News Beam Therapeutics News Editas Medicine News KALA BIO News Moderna News Intellia Therapeutics News Vertex Pharmaceuticals News Summit Therapeutics News Insmed News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
